Related Experiment Video
Updated: Jul 5, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3/FN1 axis
Jinbin Chen1,2, Boqi Rao1, Zeqin Huang1
1The State Key Lab of Respiratory Disease, The School of Public Health, Guangzhou Medical University, Guangzhou, 511436, China.
Background:
Lung cancer is the most prevalent cancer worldwide, with non-small cell lung cancer (NSCLC) accounting for 85% of all cases. Circular RNAs(circRNA) play crucial roles in regulating the progression of lung cancer. Despite the identification of a large number of circRNAs, their expression patterns, functions, and mechanisms of action in NSCLC development remain unclear.This study aims to investigate the transcriptional expressions, functions, and potential mechanisms of circRNA hsa_circ_0050386 in NSCLC.
Methods:
Quantitative real-time polymerase chain reaction (qRT-PCR) was utilized for the analysis of hsa_circ_0050386 expression. Cell proliferation was detected using the IncuCyte Live Cell Analysis System and clone formation assays. Migration and invasion of NSCLC cells were evaluated through Transwell assays. Flow cytometry was performed to assay cell cycle and apoptosis. Western blot was used to investigate protein expression. Protein binding analysis was conducted by employing pull-down assays, RNA immunoprecipitation (RIP), and mass spectrometry. The role of hsa_circ_0050386 in vivo was evaluated through the use of a xenograft model.
Results:
The study discovered that hsa_circ_0050386 displayed lower expression levels in NSCLC tissues when compared to adjacent normal tissues. Patients exhibiting lower levels of hsa_circ_0050386 expression exhibited an inverse correlation with the Clinical Stage, T-stage, and M-stage of NSCLC. Functionally, hsa_circ_0050386 suppressed the proliferation and invasion of NSCLC cells both in vitro and in vivo. A comprehensive examination exposed the interaction between hsa_circ_0050386 and RNA binding protein Serine and arginine-rich splicing factor 3 (SRSF3), resulting in the down-regulation of Fibronectin 1 (FN1) expression, which inhibits the progression of NSCLC.
Conclusions:
Our study shows that hsa_circ_0050386 suppresses the malignant biological behavior of NSCLC cells by down-regulating the expression of FN1, and may serve as a potential biomarker and therapeutic target for NSCLC treatment.
Insights
Circular RNA hsa_circ_0050386 is downregulated in non-small cell lung cancer (NSCLC), suppressing tumor growth and invasion. This circRNA may serve as a potential biomarker and therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Non-small cell lung cancer (NSCLC) is the most common cancer globally, with circular RNAs (circRNAs) playing a key role in its progression.
- The specific roles and mechanisms of circRNAs in NSCLC development are not fully understood.
- This study focuses on circRNA hsa_circ_0050386 in NSCLC.
Purpose of the Study:
- To investigate the expression patterns of circRNA hsa_circ_0050386 in NSCLC.
- To elucidate the functions and underlying mechanisms of hsa_circ_0050386 in NSCLC progression.
- To evaluate hsa_circ_0050386 as a potential diagnostic biomarker and therapeutic target for NSCLC.
Main Methods:
- Quantitative real-time polymerase chain reaction (qRT-PCR) for expression analysis.
- In vitro assays (cell proliferation, migration, invasion, cell cycle, apoptosis) and in vivo xenograft models to assess function.
- Western blot, pull-down assays, RNA immunoprecipitation (RIP), and mass spectrometry to investigate molecular mechanisms.
Main Results:
- hsa_circ_0050386 expression was significantly lower in NSCLC tissues compared to normal tissues.
- Lower hsa_circ_0050386 levels correlated inversely with NSCLC clinical stage, T-stage, and M-stage.
- hsa_circ_0050386 suppressed NSCLC cell proliferation and invasion in vitro and in vivo.
- hsa_circ_0050386 interacts with SRSF3 to down-regulate Fibronectin 1 (FN1) expression, inhibiting NSCLC progression.
Conclusions:
- hsa_circ_0050386 inhibits the malignant behaviors of NSCLC cells by down-regulating FN1 expression.
- hsa_circ_0050386 holds potential as a biomarker and therapeutic target for NSCLC treatment.
Related Concept Videos
lncRNA - Long Non-coding RNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Experimental RNAi
Abnormal Proliferation
MicroRNAs
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

